Dupilumab-Induced Extrafacial Paradoxical Persistent Erythema in an Atopic Dermatitis Patient

Dermatitis. 2021 Oct 1;32(1S):e83-e85. doi: 10.1097/DER.0000000000000785.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Dermatitis, Atopic / drug therapy*
  • Erythema / chemically induced*
  • Erythema / diagnosis
  • Erythema / drug therapy
  • Humans
  • Male
  • Skin / pathology

Substances

  • Antibodies, Monoclonal, Humanized
  • dupilumab